ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Indeed, it has been reported that in early NAFLD stages, circulating ANGPTL8 levels may be elevated, potentially serving as a compensatory response to mitigate hepatic insulin resistance and lipid dysregulation (38, 57).